Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
15.10
-0.14 (-0.92%)
At close: Jul 2, 2026, 4:00 PM EDT
15.00
-0.10 (-0.66%)
After-hours: Jul 2, 2026, 4:31 PM EDT
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $564.53 million as of July 2, 2026. Its market cap has increased by 455.23% in one year.
Market Cap
564.53M
Enterprise Value
325.16M
1-Year Change
455.23%
Ranking
Category
Stock Price
$15.10
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has increased from $402.09M to $564.53M, an increase of 40.40%. That is a compound annual growth rate of 16.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 564.53M | 35.21% |
| Dec 31, 2025 | 417.53M | 10.56% |
| Dec 31, 2024 | 377.64M | -6.08% |
| Apr 5, 2024 | 402.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Faeth Therapeutics | 590.85M |
| MiMedx Group | 588.34M |
| Crescent Biopharma | 567.88M |
| Editas Medicine | 560.14M |
| Neurogene | 558.44M |
| Assembly Biosciences | 549.73M |
| Arvinas | 541.33M |
| Shattuck Labs | 540.60M |